|1.||Hammock, Bruce D: 8 articles (07/2015 - 08/2007)|
|2.||Hwang, Sung Hee: 4 articles (12/2013 - 08/2007)|
|3.||Li, Li: 3 articles (12/2015 - 01/2013)|
|4.||Imig, John D: 3 articles (06/2012 - 09/2009)|
|5.||Ohie, Shinji: 3 articles (03/2008 - 01/2004)|
|6.||Sako, Tatsuhiko: 3 articles (03/2007 - 01/2004)|
|7.||Tsurudome, Yosuke: 3 articles (03/2007 - 01/2004)|
|8.||Shibao, Kazunori: 3 articles (03/2007 - 01/2004)|
|9.||Minagawa, Noritaka: 3 articles (03/2007 - 01/2004)|
|10.||Nakayama, Yoshifumi: 3 articles (03/2007 - 01/2004)|
04/01/2001 - "This method was applied to the pharmacokinetic studies of 1-p-(3.3-dimethyl-1-triazeno) benzoic acid in cancer patients after a single dose (i.v.) of 160, 420 or 760 mg/m(2) was administered. "
04/01/2001 - "A capillary gas chromatographic method was developed for determining 1-p-(3.3-dimethyl-1-triazeno) benzoic acid in the plasma and urine of cancer patients under pharmacokinetic study. "
04/01/2001 - "Determination and pharmacokinetic study of 1-p-(3.3-dimethyl-1-triazeno) benzoic acid in cancer patients by capillary gas chromatography."
04/01/2014 - "4-(3,4,5-Trimethoxyphenoxy) benzoic acid (compound 1) and its derivatives were selected for studying the anti-proliferative and cytotoxic effects on five human cancer cell lines. "
09/22/2010 - "The effect of inhibiting cPLA(2) activity on GL261 and LLC tumor growth was studied in mice treated with the chemical cPLA(2) inhibitor 4-[2-[5-chloro-1-(diphenylmethyl)-2-methyl-1H-indol-3-yl]-ethoxy]benzoic acid (CDIBA). "
01/01/2013 - "We tested the stability and products of BEN and benzoic acid dimethane sulfonate (BA) in plasma, blood and five renal carcinoma cell lines in vitro. "
01/01/1988 - "Inhibition of mammary carcinoma growth by retinoidal benzoic acid derivatives."
03/21/1970 - "[Significance of observation of the glucuronization degree in gynecologic carcinomas by means of I 131 -labeled orthoiodine benzoic acid]."
01/01/1963 - "[Studies on the fraction IV of benzoic acid resorption fraction of mucoprotein from the urine of patients with cancer (carcinoma cervici)]."
09/01/2004 - "A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma."
|3.||Body Weight (Weight, Body)
08/01/2006 - "Supplementation of the diet with benzoic acid resulted in a dose-dependent increase in feed intake and body weight gain and an improved feed conversion ratio. "
12/01/2011 - "The mean estimated intake of benzoic acid -0.32 mg/kg of body weight (bw) per day was below acceptable daily intake (ADI). "
07/01/2009 - "The mean benzoic acid intake was 1.58 mg kg(-1) body weight day(-1) (Tier 2) and 1.25 mg kg(-1) body weight day(-1) (Tier 3). "
12/01/2006 - "4-[3-(Ethoxycarbonyl)-2-methyl-5-(3,4-dimethoxy-phenyl)-1H-pyrrol-1-yl]-2-hydroxy-benzoic acid 3c was pointed out as the most prospective substance due to its lower acute toxicity (378 mg/kg body weight, intraperitoneally) and highest analgesic activity (up to 89.3% protection) in a dose range of 1/10 to 1/40 parts of LD(50)."
06/01/2010 - "The median intakes of both benzoic acid and sorbic acid are well below the acceptable daily intakes of 0-5 and 0-25 mg kg(-1) body weight (bw) day(-1) for benzoic and sorbic acid, respectively. "
|4.||Neoplasm Metastasis (Metastasis)
08/20/2003 - "The anti-metastatic effect of 4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid (TAC-101) was investigated using our established intrahepatic metastasis model. "
01/01/1998 - "Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells."
11/01/1999 - "TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma."
05/01/1998 - "TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span."
01/15/2007 - "Biodistributions of (67)Cu-4-(1,4,8,11-tetraazacyclotetradec-1-yl)-methyl benzoic acid tetrachloride (CPTA)-labeled mutant antibodies were measured in nude mice bearing SKOV3ip human ovarian cancer metastases. "
08/01/2004 - "The data suggest that the synergism between nitrogen starvation and benzoic acid is the result of inhibition of macroautophagy by benzoic acid and that a mechanistic understanding of this inhibition should be beneficial in the development of novel food preservation technologies."
01/01/2008 - "In this report, we demonstrate that Zygosaccharomyces bailii, a food spoilage yeast with relatively high resistance to weak acid stress, also exhibits a cytocidal response to the combination of benzoic acid and nitrogen starvation. "
01/01/2008 - "Indeed, while both benzoic acid and nitrogen starvation are cytostatic when assayed separately, the combination of these treatments is cytocidal, because macroautophagy is essential for survival during nitrogen starvation. "
08/01/2004 - "cerevisiae to either benzoic acid or nitrogen starvation is cytostatic under our conditions, the combination of the two treatments is cytocidal and can therefore be used beneficially in food preservation. "
08/01/2004 - "We identified a novel synergistic effect of the chemical preservative benzoic acid and nitrogen starvation: while exposure of S. "
|2.||cinnamic aldehyde (cinnamaldehyde)
|3.||Dimethyl Sulfoxide (DMSO)
|5.||Nitric Oxide (Nitrogen Monoxide)
|7.||4- (4- (3- adamantan- 1- ylureido)cyclohexyloxy)benzoic acid
|8.||4- (2- (5,6,7,8- tetrahydro- 5,5,8,8- tetramethyl- 2- naphthalenyl)- 1- propenyl)benzoic acid
|10.||ethyl- p- ((E)- 2- (5,6,7,8- tetrahydro- 5,5,8,8- tetramethyl- 2- naphthyl)- 1- propenyl)benzoic acid
|2.||Heterologous Transplantation (Xenotransplantation)